Atea Pharmaceuticals (AVIR) Q4 2025 Earnings

Nov 12Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.53
-0.45
-0.37
-0.29

Details

Expected EPS
-0.415
Actual EPS
-0.53
Surprise EPS
-0.12
Surprise Percent
-27.71%

Description

⁨Atea Pharmaceuticals⁩ (⁦AVIR⁩) has reported earnings of ⁦-0.53⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts